Hutchins D, Cohen B B, Steel C M
MRC Human Genetics Unit, Western General Hospital, Edinburgh, GB.
Eur J Immunol. 1990 May;20(5):961-8. doi: 10.1002/eji.1830200503.
Human B cell lines were screened for production of interleukin 6 (IL 6) by the B9 hybridoma cell bioassay. Some long-established lines such as RPMI 1788, CESS and recently established early-passage Epstein-Barr virus (EBV)-transformed lymphoblastoid lines were constitutive IL 6 producers. Other long-established lymphoblastoid lines such as RPMI 8866 and SKW6.4 and all Burkitt lymphoma lines tested were nonproducers of IL 6. Constitutive production of IL 6 in early passage lines could be enhanced by the phorbol ester phorbol 12-myristate 13-acetate (PMA) and recombinant (r)IL 4 but not by rIL 1 alpha or rIL 1 beta. Nonproducing EBV-transformed lymphoblastoid cell lines could be induced to IL 6 production by PMA, rIL 1 alpha, IL 1 beta and IL 4. Among the nonproducing lines SKW6.4 was induced to IL 6 production by PMA, rIL 1 alpha, rIL 1 beta and rIL 4, whereas RPMI 8866 was induced only by PMA, to a limited extent by rIL 1 alpha and rIL 1 beta but not at all by rIL 4. There was no induction of IL 6 by any recombinant cytokine in the two Burkitt lymphoma lines but measurable production of IL 6 was induced by PMA in one of them (EB4). Cytokines which were neither enhancers nor inducers of cell lines on their own included rIL 2, rIL 5, interferon (rIFN)-gamma, native purified IFN-alpha, tumor necrosis factor (rTNF)-alpha, rTNF-beta and purified platelet-derived transforming growth factor-beta. rIL 4 synergized with either rIL 1 alpha or rIL 1 beta in the induction of IL 6 in the nonproducing line SKW6.4. Similar effects were also seen in this line with combinations of (a) rIFN-gamma and rIL 4 and (b) IFN-alpha and both rIL 1 alpha and rIL 1 beta. rIL 4, with or without rIL 1, was more effective than rIL 6 in the induction of IgM synthesis in SKW6.4 and the effect was only partially inhibited by anti-IL 6 antiserum at a dose which totally inhibited IL 6-induced IgM production. Normal peripheral blood lymphocyte populations pre-activated by anti-immunoglobulin rosetting exhibited enhanced production of IL 6 in the presence of rIL 4 and PMA but not in the presence of rIL 1, in contrast to the behavior of adherent mononuclear blood cells which showed IL 4-induced down-regulation of IL 6 production.(ABSTRACT TRUNCATED AT 400 WORDS)
通过B9杂交瘤细胞生物测定法筛选人B细胞系,以检测白细胞介素6(IL-6)的产生情况。一些长期建立的细胞系,如RPMI 1788、CESS以及最近建立的早期传代的爱泼斯坦-巴尔病毒(EBV)转化的淋巴母细胞系,是IL-6的组成性生产者。其他长期建立的淋巴母细胞系,如RPMI 8866和SKW6.4,以及所有测试的伯基特淋巴瘤细胞系均不产生IL-6。早期传代细胞系中IL-6的组成性产生可被佛波酯佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA)和重组(r)IL-4增强,但不能被rIL-1α或rIL-1β增强。不产生IL-6的EBV转化的淋巴母细胞系可被PMA、rIL-1α、IL-1β和IL-4诱导产生IL-6。在不产生IL-6的细胞系中,SKW6.4可被PMA、rIL-1α、rIL-1β和rIL-4诱导产生IL-6,而RPMI 8866仅被PMA诱导,在一定程度上被rIL-1α和rIL-1β诱导,但完全不被rIL-4诱导。两种伯基特淋巴瘤细胞系中任何重组细胞因子均不能诱导IL-6产生,但其中一种(EB4)可被PMA诱导产生可检测到的IL-6。本身既不是细胞系增强剂也不是诱导剂的细胞因子包括rIL-2、rIL-5、干扰素(rIFN)-γ、天然纯化的IFN-α、肿瘤坏死因子(rTNF)-α、rTNF-β和纯化的血小板衍生转化生长因子-β。在不产生IL-6的细胞系SKW6.4中,rIL-4与rIL-1α或rIL-1β协同诱导IL-6产生。在该细胞系中,(a)rIFN-γ和rIL-4以及(b)IFN-α与rIL-1α和rIL-1β的组合也观察到类似效果。有或没有rIL-1时,rIL-4在诱导SKW6.4中IgM合成方面比rIL-6更有效,并且在完全抑制IL-6诱导的IgM产生的剂量下,抗IL-6抗血清仅部分抑制该效应。与贴壁单核血细胞在IL-4诱导下IL-6产生下调的行为相反,经抗免疫球蛋白玫瑰花结预激活的正常外周血淋巴细胞群体在rIL-4和PMA存在下IL-6产生增强,但在rIL-1存在下则不然。(摘要截断于400字)